Algo version: 0.98b
MREO is listed at the NASDAQ Exchange
MREO [MREO]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is MREO stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Mereo BioPharma Group plc 10 years ago, but if you had invested on Wednesday 24th of April 2019 when the price was $6.50, you would have made a loss of $-2.19 per share or -33.69%

Yes, the average daily trading liquidity for Mereo BioPharma Group plc is $3.81 million. You should therefore be able to get in and out of your positions relatively fast.

Mereo BioPharma Group plc has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Mereo BioPharma Group plc to be high [0.85 out of 1]